Data from A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Published in 2023 by
Brandon M. Huffman,
Hanrong Feng,
Kalindi Parmar,
Junning Wang,
Kevin S. Kapner 
,
Bose Kochupurakkal,
David B. Martignetti ,
Golbahar Sadatrezaei ,
Thomas A. Abrams,
Leah H. Biller ,
Marios Giannakis,
Kimmie Ng,
Anuj K. Patel,
Kimberly J. Perez,
Harshabad Singh
and other authors.
,
Bose Kochupurakkal,
David B. Martignetti ,
Golbahar Sadatrezaei ,
Thomas A. Abrams,
Leah H. Biller ,
Marios Giannakis,
Kimmie Ng,
Anuj K. Patel,
Kimberly J. Perez,
Harshabad Singh
and other authors.
